STX_Completion of enrolment_10Oct17
Shield Therapeutics is pleased to announce that the United States Patent and Trademark Office (USPTO) has allowed a composition of matter patent protecting the active…
Baird Global Healthcare Conference 2017 An audio webcast of the presentation will be available in the events section of the Company’s website. A replay will…
STX Feraccru licence agreement for Switzerland
Shield Therapeutics_Admission Announcement
Biomarker data presented at BSG
Shield Therapeutics plc Results of Fundraise
Today Shield Therapeutics announces its intention to raise funds. For the details please see the release here.